PBK_M2502

· Pharmbio Korea Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PBK_M2502, covering 2025-08-11 to 2025-08-11. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety and Efficacy of PBK_M2502 [Phase 3]